SCHEMBL28148951

SCHEMBL28148951

Cc1cccc(Cl)c1NC(=O)c1cnc(NC(=O)c2cc(F)c(Cl)cc2Cl)s1

nearest known ligand 0.68

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ LCK P06239 16/20 0.68
▸ MAPK14 Q16539 8/20 0.65
▸ MAPK13 O15264 2/20 0.65
▸ EGFR P00533 2/20 0.65
▸ FYN P06241 2/20 0.65
▸ HCK P08631 2/20 0.65
▸ SRC P12931 2/20 0.65
▸ JAK3 P52333 2/20 0.65
▸ MAPK12 P53778 2/20 0.65
▸ MAPK11 Q15759 2/20 0.65
▸ ABL1 P00519 1/20 0.59
▸ ERBB2 P04626 1/20 0.59
▸ YES1 P07947 1/20 0.59
▸ LYN P07948 1/20 0.59
▸ FGR P09769 1/20 0.59
▸ KIT P10721 1/20 0.59
▸ BCR P11274 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28148955 0.87 LCK (0.67) LCKMAPK14MAPK13EGFRFYN
SCHEMBL28147823 0.85 LCK (0.64) LCKMAPK14MAPK13EGFRFYN
SCHEMBL2774894 0.83 LCK (0.83) LCKMAPK14MAPK13EGFRFYN
SCHEMBL774358 0.82 LCK (0.68) LCKMAPK14MAPK13EGFRFYN
SCHEMBL16785698 0.81 LCK (0.67) LCKMAPK14MAPK13EGFRFYN
SCHEMBL773593 0.81 LCK (1.00) LCKMAPK14MAPK13EGFRFYN
SCHEMBL774486 0.81 MAPK14 (0.77) LCKMAPK14MAPK13EGFRFYN
SCHEMBL28844469 0.80 LCK (0.85) LCKMAPK14MAPK13EGFRFYN
SCHEMBL774144 0.80 LCK (0.78) LCKMAPK14MAPK13EGFRFYN
SCHEMBL28147824 0.80 LCK (0.85) LCKMAPK14MAPK13EGFRFYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106674150-A Dasatinib derivative with anti-tumor activity and application thereof 上海应用技术大学 2017-05-17 — — CN disclosed
Send feedback